Home - Products - Others - Other Targets - Lymphocyte Activating Pentapeptide

Lymphocyte Activating Pentapeptide

CAS No. 120484-65-3

Lymphocyte Activating Pentapeptide( ——— )

Catalog No. M42206 CAS No. 120484-65-3

Lymphocyte activating pentapeptide is a short peptide sequence found in the Fc region of human IgG1 that has the ability to activate lymphocytes. Lymphocyte activating pentapeptide can be used to study the activation mechanisms of B cells and T cells, and their role in immune responses.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lymphocyte Activating Pentapeptide
  • Note
    Research use only, not for human use.
  • Brief Description
    Lymphocyte activating pentapeptide is a short peptide sequence found in the Fc region of human IgG1 that has the ability to activate lymphocytes. Lymphocyte activating pentapeptide can be used to study the activation mechanisms of B cells and T cells, and their role in immune responses.
  • Description
    L-Leucyl-L-prolyl-L-prolyl-L-seryl-L-arginine is a peptide.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    120484-65-3
  • Formula Weight
    568.67
  • Molecular Formula
    C25H44N8O7
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hobbs M V, et al. Identification of a lymphocyte-activating pentapeptide sequence in the Fc region of human IgG1J. Journal of immunology (Baltimore, Md.: 1950), 1987, 138(8): 2581-2586.?
molnova catalog
related products
  • ErSO

    ErSO is a selective activator of anticipatory unfolded protein response (UPR) via ERα receptor. ErSO can be used in studies about anti-cancer.

  • TRAM-34

    TRAM-34(Kd=20 nM), an effective and specific inhibitor of the intermediate-conductance Ca2+-activated K+ channel (IKCa1, KCa3.1), does not block cytochrome P450.

  • Acein

    High affinity angiotensin-converting enzyme (ACE) ligand (Kd = 2.79 nM). Exhibits no significant effect on ACE enzymatic activity up to 500 nM concentration. Potentiates NMDA + D-serine-induced dopamine release from striatal slices in vitro and the striatum in vivo.